| Year |
Citation |
Score |
| 2023 |
Nassrallah WB, Ramandi D, Cheng J, Oh J, Mackay J, Sepers MD, Lau D, Bading H, Raymond LA. Activin A targets extrasynaptic NMDA receptors to ameliorate neuronal and behavioral deficits in a mouse model of Huntington disease. Neurobiology of Disease. 189: 106360. PMID 37992785 DOI: 10.1016/j.nbd.2023.106360 |
0.428 |
|
| 2020 |
Schmidt ME, Caron NS, Aly AE, Lemarié FL, Dal Cengio L, Ko Y, Lazic N, Anderson L, Nguyen B, Raymond LA, Hayden MR. DAPK1 Promotes Extrasynaptic GluN2B Phosphorylation and Striatal Spine Instability in the YAC128 Mouse Model of Huntington Disease. Frontiers in Cellular Neuroscience. 14: 590569. PMID 33250715 DOI: 10.3389/fncel.2020.590569 |
0.442 |
|
| 2020 |
Buren C, Tu G, Raymond LA. Impaired Replenishment of Cortico-Striatal Synaptic Glutamate in Huntington's Disease Mouse Model. Journal of Huntington's Disease. PMID 32310183 DOI: 10.3233/JHD-200400 |
0.306 |
|
| 2019 |
Smith-Dijak AI, Nassrallah WB, Zhang LYJ, Geva M, Hayden MR, Raymond LA. Impairment and Restoration of Homeostatic Plasticity in Cultured Cortical Neurons From a Mouse Model of Huntington Disease. Frontiers in Cellular Neuroscience. 13: 209. PMID 31156395 DOI: 10.3389/Fncel.2019.00209 |
0.373 |
|
| 2019 |
Kang R, Wang L, Sanders SS, Zuo K, Hayden MR, Raymond LA. Altered Regulation of Striatal Neuronal -Methyl-D-Aspartate Receptor Trafficking by Palmitoylation in Huntington Disease Mouse Model. Frontiers in Synaptic Neuroscience. 11: 3. PMID 30846936 DOI: 10.3389/Fnsyn.2019.00003 |
0.408 |
|
| 2019 |
Raymond L, Nassrallah W, Mackay J, Kang R. Role of extrasynaptic NMDA receptors in prodromal Huntington disease Ibro Reports. 6: S35. DOI: 10.1016/J.Ibror.2019.07.103 |
0.466 |
|
| 2018 |
Koch ET, Woodard CL, Raymond LA. Direct assessment of presynaptic modulation of cortico-striatal glutamate release in a Huntington's disease mouse model. Journal of Neurophysiology. PMID 30332323 DOI: 10.1152/jn.00638.2018 |
0.341 |
|
| 2018 |
Schmidt ME, Buren C, Mackay JP, Cheung D, Dal Cengio L, Raymond LA, Hayden MR. Altering cortical input unmasks synaptic phenotypes in the YAC128 cortico-striatal co-culture model of Huntington disease. Bmc Biology. 16: 58. PMID 29945611 DOI: 10.1186/S12915-018-0526-3 |
0.345 |
|
| 2018 |
Kovalenko M, Milnerwood A, Giordano J, St Claire J, Guide JR, Stromberg M, Gillis T, Sapp E, DiFiglia M, MacDonald ME, Carroll JB, Lee JM, Tappan S, Raymond L, Wheeler VC. HttQ111/+ Huntington's Disease Knock-in Mice Exhibit Brain Region-Specific Morphological Changes and Synaptic Dysfunction. Journal of Huntington's Disease. 7: 17-33. PMID 29480209 DOI: 10.3233/Jhd-170282 |
0.687 |
|
| 2018 |
Mackay JP, Nassrallah WB, Raymond LA. Cause or compensation?-Altered neuronal Ca2+ handling in Huntington's disease. Cns Neuroscience & Therapeutics. PMID 29427371 DOI: 10.1111/cns.12817 |
0.324 |
|
| 2017 |
Sepers MD, Smith-Dijak A, LeDue J, Kolodziejczyk K, Mackie K, Raymond LA. Endocannabinoid-specific impairment in synaptic plasticity in striatum of Huntington's disease mouse model. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29192125 DOI: 10.1523/JNEUROSCI.1739-17.2017 |
0.371 |
|
| 2016 |
Buren C, Tu G, Parsons MP, Sepers MD, Raymond LA. Influence of cortical synaptic input on striatal neuronal dendritic arborization and sensitivity to excitotoxicity in corticostriatal co-culture. Journal of Neurophysiology. jn.00933.2015. PMID 27121581 DOI: 10.1152/jn.00933.2015 |
0.3 |
|
| 2015 |
Buren C, Parsons MP, Smith-Dijak A, Raymond LA. Impaired development of cortico-striatal synaptic connectivity in a cell culture model of Huntington's disease. Neurobiology of Disease. PMID 26711622 DOI: 10.1016/j.nbd.2015.12.009 |
0.336 |
|
| 2015 |
Kolodziejczyk K, Raymond LA. Differential changes in thalamic and cortical excitatory synapses onto striatal spiny projection neurons in a Huntington disease mouse model. Neurobiology of Disease. PMID 26621114 DOI: 10.1016/j.nbd.2015.11.020 |
0.351 |
|
| 2015 |
Beccano-Kelly DA, Volta M, Munsie LN, Paschall SA, Tatarnikov I, Co K, Chou P, Cao LP, Bergeron S, Mitchell E, Han H, Melrose HL, Tapia L, Raymond LA, Farrer MJ, et al. LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory. Human Molecular Genetics. 24: 1336-49. PMID 25343991 DOI: 10.1093/Hmg/Ddu543 |
0.685 |
|
| 2014 |
Naydenov AV, Sepers MD, Swinney K, Raymond LA, Palmiter RD, Stella N. Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice. Neurobiology of Disease. 71: 140-50. PMID 25134728 DOI: 10.1016/J.Nbd.2014.08.009 |
0.366 |
|
| 2014 |
Parsons MP, Raymond LA. Extrasynaptic NMDA receptor involvement in central nervous system disorders. Neuron. 82: 279-93. PMID 24742457 DOI: 10.1016/j.neuron.2014.03.030 |
0.372 |
|
| 2014 |
Kolodziejczyk K, Parsons MP, Southwell AL, Hayden MR, Raymond LA. Striatal synaptic dysfunction and hippocampal plasticity deficits in the Hu97/18 mouse model of Huntington disease. Plos One. 9: e94562. PMID 24728353 DOI: 10.1371/Journal.Pone.0094562 |
0.311 |
|
| 2014 |
Sepers MD, Raymond LA. Mechanisms of synaptic dysfunction and excitotoxicity in Huntington's disease. Drug Discovery Today. 19: 990-6. PMID 24603212 DOI: 10.1016/j.drudis.2014.02.006 |
0.369 |
|
| 2014 |
Gladding CM, Fan J, Zhang LY, Wang L, Xu J, Li EH, Lombroso PJ, Raymond LA. Alterations in STriatal-Enriched protein tyrosine Phosphatase expression, activation, and downstream signaling in early and late stages of the YAC128 Huntington's disease mouse model. Journal of Neurochemistry. 130: 145-59. PMID 24588402 DOI: 10.1111/Jnc.12700 |
0.552 |
|
| 2014 |
Parsons MP, Kang R, Buren C, Dau A, Southwell AL, Doty CN, Sanders SS, Hayden MR, Raymond LA. Bidirectional control of postsynaptic density-95 (PSD-95) clustering by Huntingtin. The Journal of Biological Chemistry. 289: 3518-28. PMID 24347167 DOI: 10.1074/Jbc.M113.513945 |
0.373 |
|
| 2014 |
Dau A, Gladding CM, Sepers MD, Raymond LA. Chronic blockade of extrasynaptic NMDA receptors ameliorates synaptic dysfunction and pro-death signaling in Huntington disease transgenic mice. Neurobiology of Disease. 62: 533-42. PMID 24269729 DOI: 10.1016/j.nbd.2013.11.013 |
0.385 |
|
| 2013 |
Milnerwood AJ, Parsons MP, Young FB, Singaraja RR, Franciosi S, Volta M, Bergeron S, Hayden MR, Raymond LA. Memory and synaptic deficits in Hip14/DHHC17 knockout mice. Proceedings of the National Academy of Sciences of the United States of America. 110: 20296-301. PMID 24277827 DOI: 10.1073/Pnas.1222384110 |
0.679 |
|
| 2012 |
Park KH, Lu G, Fan J, Raymond LA, Leavitt BR. Decreasing Levels of the cdk5 Activators, p25 and p35, Reduces Excitotoxicity in Striatal Neurons. Journal of Huntington's Disease. 1. PMID 24353748 DOI: 10.3233/Jhd-2012-129000 |
0.516 |
|
| 2012 |
Milnerwood AJ, Kaufman AM, Sepers MD, Gladding CM, Zhang L, Wang L, Fan J, Coquinco A, Qiao JY, Lee H, Wang YT, Cynader M, Raymond LA. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice. Neurobiology of Disease. 48: 40-51. PMID 22668780 DOI: 10.1016/J.Nbd.2012.05.013 |
0.772 |
|
| 2012 |
Gladding CM, Sepers MD, Xu J, Zhang LY, Milnerwood AJ, Lombroso PJ, Raymond LA. Calpain and STriatal-Enriched protein tyrosine phosphatase (STEP) activation contribute to extrasynaptic NMDA receptor localization in a Huntington's disease mouse model. Human Molecular Genetics. 21: 3739-52. PMID 22523092 DOI: 10.1093/hmg/dds154 |
0.748 |
|
| 2012 |
Kaufman AM, Milnerwood AJ, Sepers MD, Coquinco A, She K, Wang L, Lee H, Craig AM, Cynader M, Raymond LA. Opposing roles of synaptic and extrasynaptic NMDA receptor signaling in cocultured striatal and cortical neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 3992-4003. PMID 22442066 DOI: 10.1523/JNEUROSCI.4129-11.2012 |
0.75 |
|
| 2012 |
Fan J, Gladding CM, Wang L, Zhang LY, Kaufman AM, Milnerwood AJ, Raymond LA. P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease. Neurobiology of Disease. 45: 999-1009. PMID 22198502 DOI: 10.1016/J.Nbd.2011.12.019 |
0.773 |
|
| 2012 |
Petkau TL, Neal SJ, Milnerwood A, Mew A, Hill AM, Orban P, Gregg J, Lu G, Feldman HH, Mackenzie IR, Raymond LA, Leavitt BR. Synaptic dysfunction in progranulin-deficient mice. Neurobiology of Disease. 45: 711-22. PMID 22062772 DOI: 10.1016/J.Nbd.2011.10.016 |
0.679 |
|
| 2011 |
Raymond LA, André VM, Cepeda C, Gladding CM, Milnerwood AJ, Levine MS. Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function. Neuroscience. 198: 252-73. PMID 21907762 DOI: 10.1016/J.Neuroscience.2011.08.052 |
0.429 |
|
| 2011 |
Tapia L, Milnerwood A, Guo A, Mills F, Yoshida E, Vasuta C, Mackenzie IR, Raymond L, Cynader M, Jia W, Bamji SX. Progranulin deficiency decreases gross neural connectivity but enhances transmission at individual synapses. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 11126-32. PMID 21813674 DOI: 10.1523/Jneurosci.6244-10.2011 |
0.697 |
|
| 2011 |
Singaraja RR, Huang K, Sanders SS, Milnerwood AJ, Hines R, Lerch JP, Franciosi S, Drisdel RC, Vaid K, Young FB, Doty C, Wan J, Bissada N, Henkelman RM, Green WN, ... ... Raymond LA, et al. Altered palmitoylation and neuropathological deficits in mice lacking HIP14. Human Molecular Genetics. 20: 3899-909. PMID 21775500 DOI: 10.1093/Hmg/Ddr308 |
0.652 |
|
| 2011 |
Gladding CM, Raymond LA. Mechanisms underlying NMDA receptor synaptic/extrasynaptic distribution and function. Molecular and Cellular Neurosciences. 48: 308-20. PMID 21600287 DOI: 10.1016/j.mcn.2011.05.001 |
0.403 |
|
| 2010 |
Graham RK, Deng Y, Carroll J, Vaid K, Cowan C, Pouladi MA, Metzler M, Bissada N, Wang L, Faull RL, Gray M, Yang XW, Raymond LA, Hayden MR. Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 15019-29. PMID 21068307 DOI: 10.1523/Jneurosci.2071-10.2010 |
0.312 |
|
| 2010 |
Milnerwood AJ, Raymond LA. Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease. Trends in Neurosciences. 33: 513-23. PMID 20850189 DOI: 10.1016/j.tins.2010.08.002 |
0.713 |
|
| 2010 |
Fan J, Vasuta OC, Zhang LY, Wang L, George A, Raymond LA. N-methyl-D-aspartate receptor subunit- and neuronal-type dependence of excitotoxic signaling through post-synaptic density 95. Journal of Neurochemistry. 115: 1045-56. PMID 20831617 DOI: 10.1111/J.1471-4159.2010.06994.X |
0.581 |
|
| 2010 |
McConoughey SJ, Basso M, Niatsetskaya ZV, Sleiman SF, Smirnova NA, Langley BC, Mahishi L, Cooper AJ, Antonyak MA, Cerione RA, Li B, Starkov A, Chaturvedi RK, Beal MF, Coppola G, ... ... Raymond LA, et al. Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease. Embo Molecular Medicine. 2: 349-70. PMID 20665636 DOI: 10.1002/Emmm.201000084 |
0.474 |
|
| 2010 |
Milnerwood AJ, Gladding CM, Pouladi MA, Kaufman AM, Hines RM, Boyd JD, Ko RW, Vasuta OC, Graham RK, Hayden MR, Murphy TH, Raymond LA. Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice. Neuron. 65: 178-90. PMID 20152125 DOI: 10.1016/J.Neuron.2010.01.008 |
0.752 |
|
| 2010 |
Milnerwood AJ, Gladding CM, Pouladi MA, Kaufman AM, Hines RM, Boyd JD, Ko RWY, Vasuta OC, Graham RK, Hayden MR, Murphy TH, Raymond LA. Early Increase in Extrasynaptic NMDA Receptor Signaling and Expression Contributes to Phenotype Onset in Huntington's Disease Mice (DOI:10.1016/j.neuron.2010.01.008) Neuron. 65: 436. DOI: 10.1016/j.neuron.2010.01.031 |
0.733 |
|
| 2010 |
Petkau T, Neal SJ, Milnerwood A, Orban PC, Feldman HH, Raymond L, Mackenzie IR, Leavitt BR. S1-02-03: Generation and characterization of a mouse model of progranulin deficiency Alzheimer's & Dementia. 6: S65-S65. DOI: 10.1016/J.Jalz.2010.05.190 |
0.647 |
|
| 2009 |
Fan J, Cowan CM, Zhang LY, Hayden MR, Raymond LA. Interaction of postsynaptic density protein-95 with NMDA receptors influences excitotoxicity in the yeast artificial chromosome mouse model of Huntington's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 10928-38. PMID 19726651 DOI: 10.1523/Jneurosci.2491-09.2009 |
0.613 |
|
| 2009 |
Graham RK, Pouladi MA, Joshi P, Lu G, Deng Y, Wu NP, Figueroa BE, Metzler M, André VM, Slow EJ, Raymond L, Friedlander R, Levine MS, Leavitt BR, Hayden MR. Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 2193-204. PMID 19228972 DOI: 10.1523/Jneurosci.5473-08.2009 |
0.463 |
|
| 2008 |
Cowan CM, Fan MM, Fan J, Shehadeh J, Zhang LY, Graham RK, Hayden MR, Raymond LA. Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 12725-35. PMID 19036965 DOI: 10.1523/Jneurosci.4619-08.2008 |
0.578 |
|
| 2008 |
Sornarajah L, Vasuta OC, Zhang L, Sutton C, Li B, El-Husseini A, Raymond LA. NMDA receptor desensitization regulated by direct binding to PDZ1-2 domains of PSD-95. Journal of Neurophysiology. 99: 3052-62. PMID 18400955 DOI: 10.1152/Jn.90301.2008 |
0.482 |
|
| 2008 |
Fan MM, Zhang H, Hayden MR, Pelech SL, Raymond LA. Protective up-regulation of CK2 by mutant huntingtin in cells co-expressing NMDA receptors. Journal of Neurochemistry. 104: 790-805. PMID 17971125 DOI: 10.1111/J.1471-4159.2007.05016.X |
0.335 |
|
| 2007 |
Fernandes HB, Baimbridge KG, Church J, Hayden MR, Raymond LA. Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 13614-23. PMID 18077673 DOI: 10.1523/Jneurosci.3455-07.2007 |
0.6 |
|
| 2007 |
Milnerwood AJ, Raymond LA. Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load. The Journal of Physiology. 585: 817-31. PMID 17947312 DOI: 10.1113/jphysiol.2007.142448 |
0.732 |
|
| 2007 |
Fan MM, Fernandes HB, Zhang LY, Hayden MR, Raymond LA. Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 3768-79. PMID 17409241 DOI: 10.1523/Jneurosci.4356-06.2007 |
0.653 |
|
| 2007 |
Fan MM, Raymond LA. N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease. Progress in Neurobiology. 81: 272-93. PMID 17188796 DOI: 10.1016/j.pneurobio.2006.11.003 |
0.482 |
|
| 2006 |
Cowan CM, Raymond LA. Selective neuronal degeneration in Huntington's disease. Current Topics in Developmental Biology. 75: 25-71. PMID 16984809 DOI: 10.1016/S0070-2153(06)75002-5 |
0.398 |
|
| 2006 |
Graham RK, Deng Y, Slow EJ, Haigh B, Bissada N, Lu G, Pearson J, Shehadeh J, Bertram L, Murphy Z, Warby SC, Doty CN, Roy S, Wellington CL, Leavitt BR, ... Raymond LA, et al. Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell. 125: 1179-91. PMID 16777606 DOI: 10.1016/J.Cell.2006.04.026 |
0.336 |
|
| 2006 |
Leavitt BR, van Raamsdonk JM, Shehadeh J, Fernandes H, Murphy Z, Graham RK, Wellington CL, Raymond LA, Hayden MR. Wild-type huntingtin protects neurons from excitotoxicity. Journal of Neurochemistry. 96: 1121-9. PMID 16417581 DOI: 10.1111/J.1471-4159.2005.03605.X |
0.628 |
|
| 2006 |
Shehadeh J, Fernandes HB, Zeron Mullins MM, Graham RK, Leavitt BR, Hayden MR, Raymond LA. Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease. Neurobiology of Disease. 21: 392-403. PMID 16165367 DOI: 10.1016/J.Nbd.2005.08.001 |
0.607 |
|
| 2006 |
Milnerwood AJ, Raymond LA. Synaptic abnormalities associated with huntington's disease Molecular Mechanisms of Synaptogenesis. 457-471. DOI: 10.1007/978-0-387-32562-0_32 |
0.66 |
|
| 2004 |
Li L, Murphy TH, Hayden MR, Raymond LA. Enhanced striatal NR2B-containing N-methyl-D-aspartate receptor-mediated synaptic currents in a mouse model of Huntington disease. Journal of Neurophysiology. 92: 2738-46. PMID 15240759 DOI: 10.1152/Jn.00308.2004 |
0.475 |
|
| 2004 |
Zeron MM, Fernandes HB, Krebs C, Shehadeh J, Wellington CL, Leavitt BR, Baimbridge KG, Hayden MR, Raymond LA. Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease. Molecular and Cellular Neurosciences. 25: 469-79. PMID 15033175 DOI: 10.1016/J.Mcn.2003.11.014 |
0.771 |
|
| 2004 |
Chen N, Li B, Murphy TH, Raymond LA. Site within N-Methyl-D-aspartate receptor pore modulates channel gating. Molecular Pharmacology. 65: 157-64. PMID 14722247 DOI: 10.1124/Mol.65.1.157 |
0.44 |
|
| 2003 |
Li B, Otsu Y, Murphy TH, Raymond LA. Developmental decrease in NMDA receptor desensitization associated with shift to synapse and interaction with postsynaptic density-95. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 11244-54. PMID 14657184 DOI: 10.1523/Jneurosci.23-35-11244.2003 |
0.486 |
|
| 2003 |
Li L, Fan M, Icton CD, Chen N, Leavitt BR, Hayden MR, Murphy TH, Raymond LA. Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease. Neurobiology of Aging. 24: 1113-21. PMID 14643383 DOI: 10.1016/J.Neurobiolaging.2003.04.003 |
0.478 |
|
| 2003 |
Metzler M, Li B, Gan L, Georgiou J, Gutekunst CA, Wang Y, Torre E, Devon RS, Oh R, Legendre-Guillemin V, Rich M, Alvarez C, Gertsenstein M, McPherson PS, Nagy A, ... ... Raymond LA, et al. Disruption of the endocytic protein HIP1 results in neurological deficits and decreased AMPA receptor trafficking. The Embo Journal. 22: 3254-66. PMID 12839988 DOI: 10.1093/Emboj/Cdg334 |
0.424 |
|
| 2003 |
Krebs C, Fernandes HB, Sheldon C, Raymond LA, Baimbridge KG. Functional NMDA receptor subtype 2B is expressed in astrocytes after ischemia in vivo and anoxia in vitro. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 3364-72. PMID 12716944 |
0.604 |
|
| 2002 |
Li B, Chen N, Luo T, Otsu Y, Murphy TH, Raymond LA. Differential regulation of synaptic and extra-synaptic NMDA receptors. Nature Neuroscience. 5: 833-4. PMID 12195433 DOI: 10.1038/Nn912 |
0.466 |
|
| 2002 |
Zeron MM, Hansson O, Chen N, Wellington CL, Leavitt BR, Brundin P, Hayden MR, Raymond LA. Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron. 33: 849-60. PMID 11906693 DOI: 10.1016/S0896-6273(02)00615-3 |
0.786 |
|
| 2001 |
Wagey R, Hu J, Pelech SL, Raymond LA, Krieger C. Modulation of NMDA-mediated excitotoxicity by protein kinase C. Journal of Neurochemistry. 78: 715-26. PMID 11520892 DOI: 10.1046/j.1471-4159.2001.00459.x |
0.383 |
|
| 2001 |
Zeron MM, Chen N, Moshaver A, Lee AT, Wellington CL, Hayden MR, Raymond LA. Mutant huntingtin enhances excitotoxic cell death. Molecular and Cellular Neurosciences. 17: 41-53. PMID 11161468 DOI: 10.1006/Mcne.2000.0909 |
0.775 |
|
| 2001 |
Chen N, Ren J, Raymond LA, Murphy TH. Changes in agonist concentration dependence that are a function of duration of exposure suggest N-methyl-D-aspartate receptor nonsaturation during synaptic stimulation. Molecular Pharmacology. 59: 212-9. PMID 11160855 DOI: 10.1124/Mol.59.2.212 |
0.366 |
|
| 2000 |
Hackam AS, Yassa AS, Singaraja R, Metzler M, Gutekunst CA, Gan L, Warby S, Wellington CL, Vaillancourt J, Chen N, Gervais FG, Raymond L, Nicholson DW, Hayden MR. Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domain. The Journal of Biological Chemistry. 275: 41299-308. PMID 11007801 DOI: 10.1074/Jbc.M008408200 |
0.339 |
|
| 2000 |
Chen N, Murphy TH, Raymond LA. Competitive inhibition of NMDA receptor-mediated currents by extracellular calcium chelators. Journal of Neurophysiology. 84: 693-7. PMID 10938296 DOI: 10.1152/Jn.2000.84.2.693 |
0.305 |
|
| 1999 |
Price CJ, Kim P, Raymond LA. D1 dopamine receptor-induced cyclic AMP-dependent protein kinase phosphorylation and potentiation of striatal glutamate receptors. Journal of Neurochemistry. 73: 2441-6. PMID 10582604 DOI: 10.1046/j.1471-4159.1999.0732441.x |
0.344 |
|
| 1999 |
Chen N, Luo T, Raymond LA. Subtype-dependence of NMDA receptor channel open probability. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 6844-54. PMID 10436042 |
0.393 |
|
| 1999 |
Swope SL, Moss SJ, Raymond LA, Huganir RL. Regulation of ligand-gated ion channels by protein phosphorylation. Advances in Second Messenger and Phosphoprotein Research. 33: 49-78. PMID 10218114 |
0.775 |
|
| 1999 |
Chen N, Luo T, Wellington C, Metzler M, McCutcheon K, Hayden MR, Raymond LA. Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin. Journal of Neurochemistry. 72: 1890-8. PMID 10217265 DOI: 10.1046/J.1471-4159.1999.0721890.X |
0.423 |
|
| 1999 |
Price CJ, Rintoul GL, Baimbridge KG, Raymond LA. Inhibition of calcium-dependent NMDA receptor current rundown by calbindin-D28k. Journal of Neurochemistry. 72: 634-42. PMID 9930735 DOI: 10.1046/J.1471-4159.1999.0720634.X |
0.32 |
|
| 1997 |
Umemiya M, Raymond LA. Dopaminergic modulation of excitatory postsynaptic currents in rat neostriatal neurons. Journal of Neurophysiology. 78: 1248-55. PMID 9310416 |
0.37 |
|
| 1997 |
Chen N, Moshaver A, Raymond LA. Differential sensitivity of recombinant N-methyl-D-aspartate receptor subtypes to zinc inhibition. Molecular Pharmacology. 51: 1015-23. PMID 9187268 |
0.376 |
|
| 1996 |
Price CJ, Raymond LA. Evans blue antagonizes both alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate and kainate receptors and modulates receptor desensitization. Molecular Pharmacology. 50: 1665-71. PMID 8967991 |
0.336 |
|
| 1996 |
Raymond LA, Moshaver A, Tingley WG, Huganir RL. Glutamate receptor ion channel properties predict vulnerability to cytotoxicity in a transfected nonneuronal cell line. Molecular and Cellular Neurosciences. 7: 102-15. PMID 8731479 DOI: 10.1006/mcne.1996.0008 |
0.803 |
|
| 1994 |
Roche KW, Raymond LA, Blackstone C, Huganir RL. Transmembrane topology of the glutamate receptor subunit GluR6. The Journal of Biological Chemistry. 269: 11679-82. PMID 8163463 |
0.674 |
|
| 1994 |
Raymond LA, Tingley WG, Blackstone CD, Roche KW, Huganir RL. Glutamate receptor modulation by protein phosphorylation. Journal of Physiology, Paris. 88: 181-92. PMID 7530547 DOI: 10.1016/0928-4257(94)90004-3 |
0.799 |
|
| 1993 |
Raymond LA, Blackstone CD, Huganir RL. Phosphorylation and modulation of recombinant GluR6 glutamate receptors by cAMP-dependent protein kinase. Nature. 361: 637-41. PMID 8094892 DOI: 10.1038/361637a0 |
0.593 |
|
| 1993 |
Raymond LA, Blackstone CD, Huganir RL. Phosphorylation of amino acid neurotransmitter receptors in synaptic plasticity. Trends in Neurosciences. 16: 147-53. PMID 7682348 DOI: 10.1016/0166-2236(93)90123-4 |
0.531 |
|
| 1986 |
Raymond L, Slatin SL, Finkelstein A, Liu QR, Levinthal C. Gating of a voltage-dependent channel (colicin E1) in planar lipid bilayers: translocation of regions outside the channel-forming domain. The Journal of Membrane Biology. 92: 255-68. PMID 2431149 DOI: 10.1007/Bf01869394 |
0.716 |
|
| 1986 |
Slatin SL, Raymond L, Finkelstein A. Gating of a voltage-dependent channel (colicin E1) in planar lipid bilayers: the role of protein translocation. The Journal of Membrane Biology. 92: 247-54. PMID 2431148 DOI: 10.1007/Bf01869393 |
0.71 |
|
| 1985 |
Raymond L, Slatin SL, Finkelstein A. Channels formed by colicin E1 in planar lipid bilayers are large and exhibit pH-dependent ion selectivity. The Journal of Membrane Biology. 84: 173-81. PMID 2582133 DOI: 10.1007/Bf01872215 |
0.711 |
|
| Show low-probability matches. |